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Introduction
Polybrominated diphenyl ethers (PBDEs) have 
been used as flame retardants in domestic and 
industrial applications, including computers, 
television sets, mobile telephones, furniture, 
textiles, insulation boards, mattresses, and 
upholstery furnishings (Alaee et al. 2003). Like 
poly chlorinated biphenyls (PCBs), PBDEs 
are structurally similar synthetic chemicals 
composed of two phenyl rings linked by 
oxygen (thus the designation as “ethers”; see 
Supplemental Material, Figure S1). PBDEs 
are ubiquitous in the environment, where they 
bioaccumulate, becoming toxic to animals 
and humans (Kodavanti et al. 2008). Levels 
of PBDEs have been reported to be increasing 
in some parts of the environment, in human 
blood, and in milk (McDonald 2005).
PBDEs are typically produced for indus-
trial use at three different levels of bromina-
tion, that is, penta-, octa-, and deca brominated 
diphenyl ether mixtures (La Guardia et al. 
2006; World Health Organization 1994). 
Commercially available PBDE products are 
not single compounds or even single conge-
ners but rather a mixture of congeners. The 
commercial PBDE mixture DE-71 consists 
of > 20 different congeners. Its primary 
constituents include 2,2´,4,4´-tetrabromo-
diphenyl ether (PBDE 47, ~ 38%) and 
2,2´,4,4´,5-pentabromo diphenyl ether 
(PBDE 99, ~ 49%). Collectively, these two 
congeners account for approximately 87% 
(wt/wt) of the DE-71 mixture (La Guardia 
et al. 2006). In the United States, PBDE 47 
and PBDE 99 are the two most predominant 
congeners detected in human milk, serum, 
and whole blood (Schecter et al. 2005). Like 
other lipophilic compounds, PBDEs readily 
cross the placenta into the fetus and accumu-
late in milk resulting in infant exposure during 
lactation, providing an opportunity for PBDEs 
to interfere with developmental processes 
(Kodavanti et al. 2010; Mazdai et al. 2003). 
Several studies have shown that PBDE 
exposure results in alterations in spontaneous 
behavior and in reduced learning and memory 
in mice (Viberg et al. 2003a, 2003b, 2004). 
These effects were similar to those seen 
after neonatal exposure to the structurally 
related chemicals, the PCBs (Eriksson and 
Fredriksson 1996). Rice et al. (2007) reported 
developmental delays in the acquisition of 
the palpebral reflex following repeated 
neonatal exposure to PBDE 209, along with 
changes in circulating levels of thyroxine (T4). 
However, Gee and Moser (2008) observed 
that mice exposed to PBDE 47 on postnatal 
day (PND) 10 displayed a delayed ontogeny 
of neuromotor functional end points as 
well as adult hyperactivity. Considering 
critical neurodevelopment effects including 
habituation response for PBDEs, the U.S. 
Environmental Protection Agency’s (EPA) 
derived reference dose (RfD) values were 
0.1, 0.1, and 0.2 μg/kg/day, respectively, for 
PBDEs 47, 99, and 153 (U.S. EPA 2008a, 
2008b, 2008c).
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Background: Polybrominated diphenyl ethers (PBDEs) are structurally similar to polychlorinated 
biphenyls (PCBs) and have both central (learning and memory deficits) and peripheral (motor 
dysfunction) neurotoxic effects at concentrations/doses similar to those of PCBs. The cellular and 
molecular mechanisms for these neurotoxic effects are not fully understood; however, several studies 
have shown that PBDEs affect thyroid hormones, cause oxidative stress, and disrupt Ca2+-mediated 
signal transduction. Changes in these signal transduction pathways can lead to differential gene 
regulation with subsequent changes in protein expression, which can affect the development and 
function of the nervous system.
oBjective: In this study, we examined the protein expression profiles in the rat cerebellum and 
hippocampus following developmental exposure to a commercial PBDE mixture, DE-71.
Methods: Pregnant Long-Evans rats were dosed perinatally with 0 or 30.6 mg/kg/day of DE-71 
from gestation day 6 through sampling on postnatal day 14. Proteins from the cerebellum and 
hippocampus were extracted, expression differences were detected by two-dimensional difference 
gel electrophoresis, and proteins were identified by tandem mass spectrometry. Protein network 
interaction analysis was performed using Ingenuity® Pathway Analysis, and the proteins of interest 
were validated by Western blotting.
results: Four proteins were significantly differentially expressed in the cerebellum following 
DE-71 exposure, whereas 70 proteins were significantly differentially expressed in the 
hippocampus. Of these proteins, 4 from the cerebellum and 47 from the hippocampus, identifiable 
by mass spectrometry, were found to have roles in mitochondrial energy metabolism, oxidative 
stress, apoptosis, calcium signaling, and growth of the nervous system.
conclusions: Results suggest that changes in energy metabolism and processes related to 
neuroplasticity and growth may be involved in the developmental neurotoxicity of PBDEs.
citation: Kodavanti PR, Royland JE, Osorio C, Winnik WM, Ortiz P, Lei L, Ramabhadran R, 
Alzate O. 2015. Developmental exposure to a commercial PBDE mixture: effects on 
protein networks in the cerebellum and hippocampus of rats. Environ Health Perspect 
123:428–436; http://dx.doi.org/10.1289/ehp.1408504
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In a previous study using the same 
cohort of animals, we found that DE-71 
was associated with a significant decrease 
in circulating T4 levels and accumula-
tion of PBDE congeners in various tissues, 
including the brain (Kodavanti et al. 2010). 
This suggests that PBDEs cross the blood–
brain barrier, potentially causing changes in 
neuro behavioral parameters (Kodavanti et al. 
2010). In addition, we previously reported 
that PBDEs, like PCBs, affect intra cellular 
signaling pathways including calcium homeo-
stasis, mitogen-activated protein kinase, and 
translocation of protein kinase C (PKC) 
(Fan et al. 2010; Kodavanti et al. 2005). All 
of these signaling pathways are known to 
be associated with the develop ment of the 
nervous system and involved in learning and 
memory (Kater and Mills 1991; Lein et al. 
2007). Perturbations of such signal transduc-
tion pathways in the brain could affect gene 
regulation and alter protein expression, which 
might have an ultimate effect on nervous 
system growth and function. In the present 
study, we used two-dimensional difference 
gel electro phoresis (2D DIGE)–based quan-
titative intact proteomics (QIP) to examine 
the protein expression profiles in the cere-
bellum and hippocampus of rats perinatally 
exposed to DE-71. 
Materials and Methods
Animals and chemical exposure. Timed-
pregnant Long-Evans rats (body weight 
~ 230 g; Charles River Laboratories, Portage, 
MI) were obtained on gestational day (GD) 3 
(day of insemination is GD0) and were housed 
individually in standard poly carbonate plastic 
cages containing heat-treated pine shavings 
as bedding and maintained under regulated 
temperature (21 ± 2°C), relative humidity 
(50 ± 10%), and a 12-hr light/dark cycle. 
Food (Purina Formulab Diet 5008 through 
lactation and Laboratory Rodent Diet 5001 
post weaning) and water were provided 
ad libitum (Kodavanti et al. 2010). The 
protocols and the use of animals in all experi-
ments were approved by the animal care and 
use committee of the U.S. EPA National 
Health and Environmental Effects Research 
Laboratory, and the animals were treated 
humanely and with regard for alleviation 
of suffering.
The commercial PBDE mixture DE-71 
(lot no. 1550OI18A) was a gift from the Great 
Lakes Chemical Corporation (El Dorado, AR). 
The presence of impurities, including bromi-
nated biphenyls, dioxins, and furans, has been 
reported elsewhere (Hanari et al. 2006). The 
dose of DE-71 (30.6 mg/kg/day in corn oil) 
was selected to match, on a molar basis, the 
doses of Aroclor-1254 used in previous studies 
for which we have extensive information, both 
in vitro and in vivo (reviewed by Kodavanti 
2005). The use of these previously described 
doses allows us to compare the effects of these 
two structurally related groups of chemicals. 
Dams (n = 15/dose group) were weighed and 
adminis tered DE-71 in corn oil or corn oil 
alone (2 mL/kg body weight) by oral gavage 
daily (between 0800 and 1000 hours) from 
GD6 through PND14, except on PND0 when 
the dams were not disturbed. Dams delivering 
a litter of 10–15 pups were used in the study. 
On PND4, litters were culled to 8 pups with a 
minimum of 5 males.
The reproductive outcomes, decreases 
in circulating T4 levels, assignment of 
rats for different measures, general health, 
and develop ment of the rats used in these 
studies, as well as biological relevance of the 
highest dose used in this study in terms of 
human levels, have been previously reported 
(Kodavanti et al. 2010). No changes were 
found in maternal or pup body weights or 
pup motor activity. For the present study, 
three males per treatment group, each from 
a different litter were sacrificed by guillotine 
on PND14; cerebella and hippocampi were 
dissected, quickly frozen on dry ice, and stored 
at –80°C until further processing. Dissections 
were carried out in a necropsy room at 
1000 hours in the animal facility following 
morning dosing and weighing protocols.
Protein extraction. Preparation of samples 
for proteomic analysis was as previously 
described (Kodavanti et al. 2011). Briefly, 
each tissue fraction (approximately 40 mg) 
was suspended in 200 μL of lysis buffer [8 M 
urea, 2 M thiourea, 4% CHAPS, 20 mM Tris 
pH 7.5, supplemented with protease inhibitor 
Complete® (Pierce, Rockford, IL) and phos-
phatase inhibitor, NaVO4 (Sigma, St. Louis, 
MO)]. Protein lysates were prepared using a 
2D-Clean Up Kit (GE Healthcare, Piscataway, 
NJ), and the resulting pellet was resuspended 
in focusing buffer (8 M urea, 4% CHAPS, 
30 mM Tris-HCl, pH 8.5). Protein concentra-
tion was determined with a GE Healthcare 
2D-Quant kit as directed by the manufacturer.
2D DIGE analysis. Differential protein 
expression was determined using 2D DIGE–
based QIP (Alban et al. 2003; Friedman 
et al. 2004) following a three-dye protocol 
that allows simultaneous labeling of an 
internal control and brain samples from 
exposed and unexposed rats. This protocol 
has been shown to greatly reduce the vari-
ability inherent in 2D-gel protein analysis. 
All experimental procedures were as previ-
ously described (Kodavanti et al. 2011). A 
total of three brains each from control and 
exposed rats were used. Briefly, 120 μg of 
total protein from each exposed sample and 
from each control sample was labeled with 
400 pmol of the cyanine dyes Cy5 and Cy3 
(GE Healthcare), respectively. The internal 
control was created by pooling 60 μg from 
control and exposed samples followed by 
labeling with 400 pmol Cy2.
Isoelectric protein separation of labeled 
samples (n = 3 animals/group) was performed 
using immobilized pH gradient strips [13 cm, 
pI (isoelectric point) range, 3–10; GE 
Healthcare]. Protein separation in the second 
dimension was done with SDS (12%)-PAGE 
gels (4% stacking) casted on low fluorescence 
glass plates (13 cm; GE Healthcare). Each 
control sample was run against each exposed 
sample for a total of nine gels, improving 
statistical power. The resulting gels were 
scanned using a Typhoon 9410 imaging 
system (GE Healthcare) and then were fixed 
and stained with colloidal Coomassie for 
further processing.
Protein identification. Protein identifica-
tion was performed as previously described 
(Winnik et al. 2012). Briefly, spots with 
statistically significant expression changes as 
determined by DeCyder 2D software (GE 
Healthcare) and of sufficient amount of 
protein were excised from the gels with the 
Ettan Spot Picker (GE Healthcare). In-gel 
protein digestion was carried out using 
modified trypsin, and matrix-assisted laser 
desorption ionization (MALDI) tandem mass 
spectrometry (MS/MS) data were acquired 
with either a 4700 or a 4800 Proteomics 
Analyzer MALDI tandem time-of-flight 
(TOF/TOF) mass spectrometer (Applied 
Biosystems). The proteins were identified by 
a combination of peptide mass finger printing 
and the sequence-tag approach (DeKroon 
et al. 2011). The peptide mass finger printing 
and sequence tag data were evaluated with 
Mascot scores (Mascot® Search Engine; 
Matrix Science; http://www.matrixscience.
com/) or “Aldente” online proteomic software 
(Winnik et al. 2012). Keratin and trypsin 
auto lysis contaminant peaks were identified 
and excluded from the MS/MS analysis. 
This step was followed by MALDI MS/MS 
sequencing, and the final protein identification 
was performed using Protein Pilot 3.0 software 
(Applied Biosystems) and the Mascot® Search 
Engine, searching against the rat species data
base within the non redundant National Center 
for Biotechnology Information data base 
(NCBI nr) or the SwissProt database (ExPasy 
Bioinformatics Resource Portal 2013). Finally, 
mass-selected MALDI MS/MS spectra acquisi-
tion was performed to further increase protein 
sequence coverage. Proteins were identified 
based on at least two unique MS/MS peptide 
sequences with confidence scores > 95% 
(corresponding to the overall minimum 
protein identification confidence level of 
99.75%) based on Protein Pilot 3.0 peptide 
and protein percent confidence score criteria. 
Alternatively, an MS/MS-based MASCOT 
protein score of ≥ 40 was considered acceptable 
(Winnik et al. 2012).
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Western blot analysis. Each sample was 
prepared as described previously (Kodavanti 
et al. 2011). Briefly, 200 mg of tissue was 
sonicated in 200 μL RIPA buffer (Sigma) with 
Complete® protease inhibitor cocktail (Roche) 
and centrifuged at approximately 20,000 × g 
for 10 min at 5˚C. The supernatant was 
collected and protein content was determined 
with a 2D-Quant kit (GE Healthcare). A 
10-μg aliquot of total protein was separated on 
10% SDS-PAGE gels, the proteins were trans-
ferred to polyvinylidene difluoride membranes 
for 16 hr in a cold room, and the membranes 
were probed with monoclonal antibodies from 
Abcam, (Cambridge, MA) against anti-protein 
disulfide isomerase A3 (PDIA3; ab10287) 
and α-tubulin (ab7291) as an internal 
loading control (Alban et al. 2003). We chose 
PDIA3 [also called endoplasmic reticulum 
resident protein 57 (ERP57)] for Western 
blot analysis to validate the 2D-gel data set 
because it possesses multiple functional roles 
in central nervous system physiology that 
were impacted by gestational and lactational 
exposure to DE-71. 
Protein functional analysis. We used the 
NCBI databases (http://www.ncbi.nlm.nih.
gov/) to research protein functional ontology. 
The resulting information was used to separate 
the differentially expressed proteins into 
functional groups. Follow-up analysis with 
Ingenuity® Pathway Analysis (IPA) software 
v9.0-3210 (Ingenuity _ENREF_31; http://
www.qiagen.com/ingenuity) provided 
additional correlations between identified 
proteins and was used to generate functional 
networks as described previously (Kodavanti 
et al. 2011). Networks were ranked by their 
scores, which are based on a p-value calcula-
tion on the probability that network proteins 
are part of the network by random chance 
and are equal to the negative exponent of this 
calculation. For example, a score of 25 reflects 
highly relevant networks with p-values of 
10–25. Canonical overlays had p-values ≤ 0.05.
Statistics. The digital images from the 
Typhoon system were analyzed with DeCyder 
2D software to determine changes in protein 
levels across gels and for pair wise compari-
sons of individual Cy3- and Cy5-labeled 
samples (Friedman et al. 2004). Pair-wise 
comparisons of each PND14 control and the 
corresponding DE-71 sample, along with the 
pooled internal standard present on each gel, 
was performed using the DeCyder differen-
tial in-gel analysis module. We used 2 SDs 
from the mean volume ratio (95th percentile 
confidence interval) as a threshold to deter-
mine the levels of significance for a given set 
of samples. Statistical analysis and gel-to-gel 
comparisons were performed with Decyder’s 
Biological Variation Analysis module 
(DeKroon et al. 2011). Data were log2 trans-
formed, and protein changes between control 
and DE-71–exposed rats were analyzed using 
Student’s t-test (p < 0.05). Fold changes 
calculated as the ratio of the treated to the 
control were derived on the mean expression 
changes determined. Significance for Western 
analysis was determined by t-test at p ≤ 0.05 
(Microsoft Excel 2013; Microsoft Corp., 
Redmond, WA).
Results
Differential protein expression analysis. 
Perinatal DE-71 exposure had a signifi-
cant impact on cerebellar and hippocampal 
protein expression at PND14. Figure 1 
shows representative examples of gels 
stained with three dyes (as scanned by the 
Typhoon 9410 imaging system) identifying 
protein spots that are significantly different 
in the cerebellum (Figure 1A) and hippo-
campus (Figure 1B) of DE-71–exposed 
animals compared with controls. These 
images, analyzed by DeCyder 2D software, 
resulted in three-dimensional (3D) images 
representing changes in protein levels in the 
cerebellum (Figure 2A) and hippocampus 
(Figure 2B). Analysis of the 3D images identi-
fied 4 and 70 protein spots as differentially 
expressed in the cerebellum and hippocampus, 
respectively.
Proteins available in amounts sufficient 
for downstream procedures were identified 
by MALDI TOF/TOF MS analysis. This 
included all 4 of the cerebellar protein spots 
and 47 of the 70 differentially expressed 
hippocampal protein spots (p < 0.05; 
Figure 1). Protein identification features, 
including accession number, iso electric point, 
molecular weight, and Mascot protein score, 
are presented in Supplemental Material, 
Table S1. Seven of the identified hippo-
campal proteins had two post translational 
modifications [albumin (ALBU), glial fibril-
lary acidic protein (GFAP), dihydropyrim-
idinase-related protein 2 (DPYL2), DPYL5, 
Figure 1. Representative 2D DIGE gels from the cerebellum (A) and hippocampus (B) showing proteins 
whose expression was different in rats developmentally exposed to DE‑71 compared with controls. 
(Left) The numbered protein spots represent differentially expressed proteins identified in Supplemental 
Material, Table S1. The arrows point to proteins that were altered in tissue from DE‑71–exposed rats as 
determined by DeCyder 2D software; 4 proteins were altered in the cerebellum, and 70 proteins were 
altered in the hippocampus. (Right) Images illustrate protein spots fluorescently labeled with Cy2, Cy3, or 
Cy5. DeCyder 2D software corrected for variation in spot colors occuring with individual gel staining. Red 
represents proteins with higher expression in the treated sample; green indicates proteins with higher 
levels in the control sample; and white or yellow represents proteins with no difference in expression level 
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heat shock protein 74 (HSP74), creatinine 
kinase B-type (KCRB), and tubulin alpha-1B 
(TBA1B)], one had two isoforms [glyceral-
dehyde-3-phosphate dehydrogenase (G3P)], 
and one protein (DPYL3) was identified in 
4 isoforms; thus, the final count for identi-
fied hippocampal proteins was 35. All of the 
cerebellar proteins (4/4) (see Supplemental 
Material, Table S2) and approximately 94% 
(66/70) of the hippocampal proteins (see 
Supplemental Material, Table S3) affected 
were up-regulated by DE-71 exposure.
Protein functional analysis. Using the 
NCBI and Swiss-Prot databases, we ascer-
tained individual protein functions based 
on the specific accession numbers deter-
mined from protein identification software 
(DeCyder 2D software). Proteins were then 
grouped into larger functional categories 
by correlating changes in expression with 
possible functional response to and conse-
quences of DE-71 exposure. Differentially 
expressed proteins in the cerebellum were 
related to growth functions associated with 
carbohydrate metabolism [alpha-enolase 
(ENOA) and fructose-bisphosphate aldolase C 
(ALDOC)] and RNA processing [heteroge-
neous nuclear ribonucleo protein (HNR) 
H2 and heterogeneous nuclear ribo nucleo-
protein A3 (ROA3)] (see Supplemental 
Material, Table S2). Growth functions were 
also prominently displayed in the identified 
hippocampal proteins, with 18 of the 35 iden-
tified proteins falling into this general category. 
Proteins with roles in cyto skeleton assembly 
[e.g., septin-5 (SEPT5), myristoylated alanine-
rich-C-kinase (MARCKS)], energy metabo-
lism (e.g., KCRB), neuro transmission [e.g., 
glutamine synthetase (GLNA)], and cell 
division [transitional endoplasmic reticulum 
ATPase (TERA)], as well as proteins with 
roles in common with those identified in the 
cerebellum, such as carbohydrate metabolism 
[ENOA and gamma-enolase (ENOG)] and 
RNA processing (HNRH1), are included in 
this group. The next major functional group in 
the hippocampus is related to proteins linked 
to the stress response and is indicative of the 
adverse effects of DE-71 exposure. Protein 
markers of neuronal death (GFAP) and 
microglial cell activation (ALBU); heat shock 
proteins that act as protein chaperones (e.g., 
HSP74 and HSP7C); and PDIA3, a protein 
involved in redox metabolism, were differen-
tially expressed in DE-71–exposed rat hippo-
campi. Several proteins with roles in neuronal 
plasticity, possibly in response to damage, 
were also identified. For example, proteins 
involved in neuronal develop ment [e.g., 
DPYL2, DPYL3, DPYL4, dynactin subunit 2 
(DCTN2)] and synapto genesis (DCTN2) 
were up-regulated. The final functional group 
is related to protein chemistry and is composed 
of proteins with roles in protein catabolism 
[proteosome subunit alpha type-1 (PSA1)], 
complex assembly [glucose regulated protein 
78 kDa (GRP78)], formation of secondary 
structure [T-complex protein 1 subunit (TCP) 
epsilon and gamma], and synthesis [eukaryotic 
translation initiation factor 4B (Q5RKG9)].
The results of the IPA performed on 
the identified hippocampal proteins agreed 
closely with the functional ontology results. 
The network in Figure 3A represents the 
top network, with a score of 25 (p < 10–25). 
Fourteen of the 35 identified proteins fell 
within this network, which included proteins 
involved in post-translation modifica-
tion, protein folding, and drug metabolism. 
Canonical overlays highlighted the nuclear 
factor erythroid 2-related factor (Nrf2)-
mediated oxidative stress, glucose metabolism, 
and protein modification pathways. The 
network in Figure 3B shows the results from 
merging three of the remaining top networks 
with scores of 17, 9, and 2 (p < 10–17, 10–9, 
and 10–2, respectively), which included 
proteins with roles in cellular function and 
maintenance, cellular assembly and organiza-
tion, and nervous system development and 
function. The remaining DE-71–affected 
hippocampal proteins are in this network. For 
example, the enolases alpha-enolase (ENOA) 
and gamma-enolase (ENOG) participate in 
glucose metabolism, and eukaryotic translation 
initiation factor 4B, which binds ribosomes 
and functions in synthetic processes, contrib-
utes to cell growth and maintenance. Tubulin 
and the dihydropyrimidinase-related proteins 
(DPYL2, DPYL3, and DPYL5) have roles in 
cyto skeleton and axonal growth and contribute 
to both cell organization and neuronal 
development. Similar functions can be identi-
fied for the other proteins (see Supplemental 
Material, Table S3). Canonical and functional 
overlays include protein modification and 
glucose metabolism as in network I, but they 
also include signaling and neuronal functions.
Western blot confirmation. We vali-
dated 2D DIGE results by Western blot 
analysis of PDIA3 (also called as ERP57) in 
the hippocampus of control (0 mg/kg) and 
DE-71–exposed (30.6 mg/kg) rats as shown 
in Supplemental Material, Figure S2A. The 
mean fold-change (± SE) was 1.78 ± 0.28 in 
DE-71–exposed rats compared with controls; 
data were from three independent experiments 
(n = 3 per treatment). These data closely match 
that of the 2D-gel experiment (1.67-fold 
increase; see Supplemental Material, Table S3). 
Supplemental Material, Figure S2B, shows the 
representative protein bands for PDIA3 and 
the housekeeping protein, α-tubulin (used 
as an internal control), found in the hippo-
campus of control and treated rats. 
Discussion
There is growing evidence that PBDEs have an 
adverse impact on neuro behavioral and func-
tional development. Epidemiological studies 
have shown associations between prenatal 
PBDE exposure and reduced development 
in children, including both psychomotor 
development and Full-Scale IQ performance 
(Eskenazi et al. 2013; Herbstman et al. 2010). 
These epidemiological studies are supported 
by animal studies in which PBDE exposure 
delayed the ontogeny of neuromotor function, 
Figure 2. Three‑dimensional visualization of protein spots differentially expressed in the cerebellum (A) and 
hippocampus (B) of DE‑71–exposed rats compared with controls. Examples show how high [A, left; ENOA 
(2C)] and low [A, right; HNRH2 (1C)] expression changes or up‑ [B, left; G3P (40H)] and down‑ [B, right; 
MARCKS (6H)] regulation were identified by the DeCyder 2D software. Details for the proteins are provided 
in Supplemental Material, Table S1. 
ENOA (2C)
Control DE-71 Control DE-71
Control DE-71 Control DE-71
G3P (40H) MARCKS (6H)
HNRH2 (1C)
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resulting in hyperactivity in adult mice (Gee 
and Moser 2008). Viberg et al. (2003a, 
2003b, 2004) reported persistent aberrations 
in spontaneous behavior and habituation 
capability in mice after a single developmental 
exposure (PND10) with PBDEs 99, 153, 
and 209. A study in our laboratory on devel-
opmental exposure to DE-71 found that 
accumulation of PBDE congeners in various 
tissues, including the brain, were associated 
with subtle changes in parameters of neuro-
behavior and decreased circulating T4 levels 
Figure 3. Ingenuity® Pathway Analysis showing functional correlates of proteins that were affected in the hippocampus of rats developmentally exposed to 
DE‑71. (A) The most highly correlated network (score of 25). (B) Merged network of the next three highest ranked networks (scores of 17, 9, and 2). Symbols for 
differentially expressed proteins are in shades of red, with color intensity related to level of change, and symbols for networked proteins (from the Ingenuity 
database) are white. Associated canonical overlays are indicated by blue‑outlined ovals and dotted blue lines. 
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(Kodavanti et al. 2010). Perturbed thyroid 
hormone homeostasis, altered cell signaling 
including calcium homeostasis, and neuro-
transmitter changes have been postulated as 
critical events leading to the adverse neuronal 
effects of persistent organic pollutants such 
as PBDEs (Kodavanti 2005). In the present 
study, we examined changes in protein profiles 
in the cerebellum and hippocampus following 
developmental exposure to DE-71. The results 
indicated that peri natal exposure to DE-71 
altered the expression of proteins associated 
with key metabolic pathways involved in cell 
growth, protein metabolism, neuronal plas-
ticity, and stress responses (Figure 3; see also 
Supplemental Material, Tables S2 and S3). 
The effect of DE-71, as measured by the 
number of altered proteins, was greater in 
the hippocampus than in the cerebellum, 
most likely due to onto genetic differences in 
the two brain areas during time of exposure 
(GD6–PND14). In contrast to most brain 
regions, both the hippocampus and cere-
bellum largely develop post natally (Buell 
et al. 1977). However, postnatal hippocampal 
neuro genesis continues at some level for up to 
3 months of age in the rat, whereas cerebellar 
neuro genesis begins to decline at about 6 days 
post birth (Altman and Das 1965).
Maintaining normal cell function requires 
an adequate energy supply, especially during 
growth and under conditions of stress. We 
found differential expression of multiple 
proteins with roles in energy production 
in tissue of rats developmentally exposed 
to DE-71. Glycolysis seemed to be mainly 
affected, suggesting greater changes in the 
levels of cyto plasmic proteins. ENOA, a 
component of glycolysis that generates ATP 
through high energy intermediates (Wold 
1971), was significantly up-regulated both 
in the cerebellum and hippocampus. Alm 
et al. (2006) reported a similar increase in 
the mouse hippocampus following a single 
oral dose of PBDE 99 on PND10. In the 
same pathway, ALDOC was up-regulated in 
the cerebellum, whereas G3P and phospho-
glycerate kinase 1 (PGK1) were up-regulated 
in the hippocampus (see Supplemental 
Material, Tables S2 and S3). ALDOC splits 
fructose 1,6-bisphosphate into dihydroxy-
acetone phosphate and G3P. G3P and 
PGK1 catalyze the sixth and seventh steps 
of glycolysis, generating ATP. G3P is also 
the precursor to pyruvate which feeds into 
the Krebs cycle. This is particularly impor-
tant in the brain, which uses primarily 
mito chondrial oxidative phosphorylation 
as its source of ATP (Hall et al. 2012). IPA 
identified gluconeogenesis/glycolysis to be 
one of the highest ranked altered pathways in 
this data set (Figure 3). Additional proteins 
related to glycolysis (pyruvate dehydroge-
nase E1; ODPB), the Krebs cycle (malate 
dehydrogenase; MDHC), electron trans-
port (NADH-ubiquinone oxido reductase; 
NDUS1), and energy transduction (KCRB) 
were differentially expressed in the hippo-
campus. KCRB is specific for brain tissue 
and plays a major role in generating ATP 
under conditions of high energy demand 
(Mahadevan et al. 1984). Although creatine 
kinase is widely regarded as a soluble enzyme, 
the brain isoform is associated with synaptic 
plasma membrane (Lim et al. 1983). It 
has been shown to be regulated by thyroid 
hormones, with increased serum KRCB 
levels being associated with hypothyroidism 
(Beyer et al. 1998). Developmental DE-71 
exposure is known to cause hypo thyroidism 
by decreasing circulating T4 levels (Kodavanti 
et al. 2010), and this effect could play a 
role in the alterations of KRCB seen in 
the hippocampus. Mukherjee et al. (2013) 
recently reported that PBDE-47 altered 
several proteins related to energy metabo-
lism, including ENOA. PBDE-154 has 
been shown to deplete mitochondrial ATP 
by inter acting with the inner mitochondrial 
membrane, inhibiting electron transport, and 
reducing the membrane potential (Pereira 
et al. 2014), and PBDE-49 inhibited electron 
transport complexes IV and V in brain mito-
chondria (Napoli et al. 2013). These data 
highlight the critical role of energy metabo-
lism in DE-71’s mode of action.
In addition to ENOA, proteins related 
to nucleo tide metabolism were also altered 
both in the cerebellum and hippocampus. 
HNRH2 and HNRH1 were up-regulated in 
the cerebellum and hippocampus, respectively. 
In addition, ROA3 was increased in the cere-
bellum and heterogeneous nuclear ribonucleo-
protein K (HNRHK) was increased in the 
hippocampus by DE-71. These proteins have 
multiple functions in the processing of hetero-
geneous nuclear RNAs into mature mRNAs 
and can act as trans-factors in regulating gene 
expression (Chaudhury et al. 2010). 
In another growth-related function, 
several hippocampal proteins related to 
cytoskeleton structure and axonogenesis 
were changed by DE-71 (see Supplemental 
Material, Table S3). Tubulin alpha-1B chain 
(TBA1B), tubulin alpha-1C (TBA1C), 
SEPT5, and neuro filament light polypeptide 
(NFL) were up-regulated, whereas MARCKS 
was down-regulated. Along with actins, 
tubulins are abundant cyto skeletal proteins 
that support diverse cellular processes, 
including micro tubule and micro filament 
structure and function (Lundin et al. 2010). 
Septins are GTP-binding proteins with roles 
in vesicle trafficking, apoptosis, remodeling 
of the cytoskeleton, neuro degeneration, 
and neoplasia (Hall et al. 2005). MARCKS 
protein has been implicated in actin 
cyto skeletal rearrange ment in response 
to extra cellular stimuli (Eun et al. 2006). 
Mukherjee et al. (2013) reported a similar 
increase in cyto skeletal proteins (tubulin beta 
chain and actin) following BDE-47 exposure 
in the snail, Crepidula onyx. In neural stem/
progenitor cells, BDE-209 and/or BDE-47 
decreased the expression of cyto skeletal 
proteins such as cofilin-1 and vimentin (Song 
et al. 2014). Together, these data suggest 
perturbed neuronal processes, either as a 
disruption of normal neurite outgrowth or 
possibly as a repair response to the DE-71–
induced neuro toxic effects, in agreement 
with the study of Viberg and Eriksson (2011) 
in which changes in proteins involved in 
maturation of brain, neuronal growth, and 
synaptogenesis were associated with changes 
in learning and memory resulting from 
PBDE exposure.
Further evidence of an impact on neuro-
genesis can be seen with the effect of DE-71 
on the dihydropyrimidinase-related proteins 
(DPYL2, DPYL3, and DPYL5) for which 
multiple isoforms were affected. These proteins 
are involved in facilitating neuronal growth 
cone migration and promoting microtubule 
assembly, and they have a role in synaptic 
signaling. They are required for signaling 
by the cell-adhesion semaphorin proteins 
(Suzuki et al. 2003). Dihydropyrmidinase-
related proteins have been targets for oxida-
tive stress in brains affected by Alzheimer’s 
disease (Castegna et al. 2002), and both DPYL 
proteins and their companion semaphorins 
have been reported to be up-regulated in 
response to nervous system injury (Murphey 
et al. 1999). In the present study, IPA identi-
fied axonal guidance, semaphorin signaling, 
and neuro degenerative process as important 
pathways in DE-71 neuro toxicity (Figure 3). 
Also involved in synaptic plasticity, the 
dynactin protein DCTN2 was up-regulated 
by DE-71. Dynactin is necessary for stabiliza-
tion of the synapse and for dendritic arboriza-
tion during development (Eaton et al. 2002; 
Murphey et al. 1999). Dingemans et al. (2007) 
observed that PBDE-47 exposure reduced 
long-term potentiation together with changes 
in post synaptic proteins involved in synaptic 
plasticity in the mouse hippocampus.
Multiple proteins up-regulated in the 
present study suggest possible pathways for 
PBDE-induced neurotoxicity. For example, 
GFAP, a marker of neuronal damage, was 
up-regulated. GFAP is expressed in the central 
nervous system in astrocytes and is involved 
in cell communication and the functioning 
of the blood–brain barrier. However, after 
neuronal damage, astrocytes infiltrate the 
damaged area and GFAP levels increase 
(O’Callaghan and Sriram 2005). Increases in 
brain GFAP have been documented following 
exposure to environmental chemicals (Brock 
and O’Callaghan 1987) and have become 
Kodavanti et al.
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an accepted biomarker for neurotoxicity 
(O’Callaghan and Sriram 2005).
Protein metabolism was heavily influenced 
by DE-71 exposure in our study. Our data 
show up-regulation of proteins involved in 
protein folding (T-complex protein 1 subunit 
gamma; TCPG) and complex assembly 
(GRP78). In addition, several proteins impor-
tant in the brain’s response to stress were 
affected. In the hippocampus, proteins related 
to the chaperone/ubiquination pathway 
were increased by DE-71 (see Supplemental 
Material, Table S3). Heat shock proteins 
such as HSP74, HSP7C, and HSP105 were 
all increased approximately 1.6- to 1.7-fold 
in DE-71-treated animals compared with 
vehicle controls (60–70% increase over 
controls). HSPs are molecular chaperones 
that have roles in protein synthesis, protect 
against stress by aiding in refolding of slightly 
damaged proteins, or can transfer severely 
damaged proteins to the proteasome for 
degradation (Becker and Craig 1994). Using 
IPA, we found several ontology groupings that 
highlighted protein ubiquination pathways 
as being significantly impacted in the hippo-
campus by DE-71 (Figure 3). 
Of particular interest, the only two 
proteins that showed decreased expression in 
DE-71–exposed rats have roles in immune 
cell activation. As described above, MARCKS 
has a role in cyto skeleton rearrangement in 
response to external stimuli. In addition, 
induction of MARCKS has been observed 
following microglial activation, linking it to 
neuro degenerative processes (Murphy et al. 
2003). However, results of the present study 
indicate a decrease (–1.39-fold) in MARCKS 
protein. The second down-regulated protein, 
PSA1 (also known as Macropain; –1.40 fold), 
in addition to its role in protein degrada-
tion as a component of the proteosome, is 
known to mediate the LPS-induced activation 
of macrophages with consequent transcrip-
tion of genes that encode proinflammatory 
regulators of the immune response (Martínez-
Solano et al. 2009). Thus, depletion of these 
proteins by DE-71 could negatively impact 
the brain’s capacity to mount a defense 
against damage and/or insult.
It is important to note that there is consid-
erable crossover in secondary functions for 
many of the proteins listed. For example, 
in Supplemental Material, Table S3, the 
enolases were grouped under “Cell growth 
and function” because of their roles in carbo-
hydrate metabolism and glycolysis, but they 
also have roles in stress response in neurons 
(Díaz-Ramos et al. 2012). Glutamine synthe-
tase is important in the brain for GABA 
(γ-aminobutyric acid) synthesis and is also 
a significant player in energy metabolism as 
part of the citric acid cycle. Proteins with 
general roles in cell proliferation in the 
nervous system often have roles in neuronal 
function. For example, DCTN2 is impor-
tant in chromosome alignment during mitosis 
(Quintyne et al. 1999) and may also play a 
role in neuro genesis and synapto genesis 
during brain develop ment or in plasticity 
following damage. Dynactin is important in 
linking Sun1/2 and Syne/Nesprin-1/2 to the 
nuclear membrane; both of these proteins 
are important to the nuclear movement that 
is critical for neuro genesis and neuronal 
migration (Zhang et al. 2009). This process 
is required for micro tubule extension during 
growth cone remodeling and axonal growth 
(Grabham et al. 2007). The nature of many 
of the proteins affected by DE-71 exposure is 
suggestive of neuronal damage and plasticity 
related to repair and homeostatic mechanisms.
PDIA3, also known as ERp57, was 
chosen for our validation experiments 
because of its multiple functions in the 
processes identified by the proteomics 
data set. The expression of PDIA3 protein 
was up-regulated in both 2D DIGE and 
Western blot analyses. As a constituent of 
the endoplasmic reticulum, in conjunction 
with other chaperone proteins, PDIA3 assists 
in glyco protein folding (Bedard et al. 2005), 
and it also plays a role in synaptic plasticity 
(Hofmann and Kirsch 2012). A common 
mode of action could be expected between 
chemically induced neuro toxicity and 
Figure 4. Schematic showing possible adverse outcome pathways for the developmental neurotoxicity of PCBs/PBDEs using a systems biology approach. The 
schematic highlights the pathways that link PCB/PBDE exposure to neurochemical changes and genomic and proteomic changes that may lead to structural and 
functional changes. Proteins listed in red were altered by developmental exposure to PCB; those listed in blue were altered by developmental PBDE exposure. 
Although different proteins were altered by these structurally related chemicals (PBDEs and PCBs), it is very interesting to note that similar pathways were altered by 
the developmental exposure and hence may have a common mode of action for the adverse effects associated with these chemicals. 
aData from Kodavanti et al. (2005, 2010). bData from the present study and Kodavanti et al. (2011). cData from Ibhazehiebo et al. (2011). dData from Eriksson et al. (2001), Eskenazi et al. 
(2013), Herbstman et al. (2010), and Rice et al. (2007).
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neuro degenerative diseases. In this context, 
it was reported by Erickson et al. (2005) that 
PDIA3 acts as a carrier protein for β-amyloid 
and that plaque formation in Alzheimer’s 
disease may be due to faulty endo plasmic 
reticu lum post translational processing. In 
addition, Wilhelmus et al. (2011) proposed 
that PDIA3 may be involved in α-synuclein 
accumulation in Parkinson’s disease. 
PBDEs belong to the family of organo-
halogen chemicals that are ubiquitous around 
the world, persistent in the environment, 
and of continued concern in health issues. 
Previously, our laboratory conducted a 
similar proteomics study on the PCB mixture 
Aroclor 1254 (Kodavanti et al. 2011). In 
experiments with these structurally related 
compounds, we observed an increase in 
proteins related to energy metabolism, 
chaperone function, neuronal plasticity, 
and neuronal damage, similar to that found 
with the PBDE mixture in the present study 
(Figure 4). Disruptions in PKC activation, 
calcium signaling, oxidative stress, and thyroid 
hormone perturbations are recognized as 
adverse outcome pathways for PCB exposure 
(Figure 4; Kodavanti 2005; Kodavanti et al. 
1998). In the present study, MARCKS protein 
was down-regulated by DE-71. MARCKS is a 
widely distributed primary substrate for PKC 
in the cytoplasm and is involved in neurite 
outgrowth and dendritic spine morphology 
during develop ment (Calabrese and Halpain 
2005). The Aroclor 1254–dependent decrease 
in PKC could have been due, in part, to a 
lack of the MARCKS substrate, suggesting 
that a similar loss in PKC activity could occur 
after DE-71 exposure, with possible effects 
on nervous system development (Figure 4). 
Adverse effects of these two groups of chemi-
cals included both morphometric and func-
tional changes. With Aroclor 1254 exposure, 
both dendritic growth and branching was 
decreased following developmental exposure 
(Lein et al. 2007), along with decreased 
motor activity and learning and memory 
deficits (Eriksson and Fredriksson 1996). 
In agreement with effects of Aroclor 1254, 
suppression of thyroid hormone–mediated 
dendrito genesis and dendritic branching 
pattern (Ibhazehiebo et al. 2011), as well as 
decreased motor activity and memory deficits, 
have been reported with PBDE exposure 
(Herbstman et al. 2010). Thus, we propose 
common adverse-outcome pathways within 
this extended family of chemicals (Figure 4). 
Current proteomic data support the idea that 
neuro toxic effects observed after develop-
mental DE-71 exposure could arise from the 
disruption of the normal onto genetic pattern 
of nervous system growth and develop-
ment through perturbation of intra cellular 
signaling pathways, causing  oxidative stress 
and disrupting energy homeostasis.
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